Researchers explored the effects of opioid-sparing multimodal anesthesia embedded within an ERAS protocol on postoperative recovery in gynecologic oncologic surgery.
Researchers sought to determine whether fixed-duration treatment with venetoclax + obinutuzumab/ibrutinib would have similar efficacy to continuous ibrutinib therapy in CLL.
Survivors of nearly all types of adolescent and young adult cancer have an increased risk for developing a subsequent primary neoplasm, according to a study pub ...
Investigators explored the association between income and patient- and treatment characteristics, diagnosis through screening, and survival of patients with synchronous metastasized CRC.
Early-onset oral cavity squamous cell carcinoma (EO-OCSCC) is increasingly presenting as tongue tumors, and cases in women are increasing, according to a study published online Jan. 31 in ...
A prospective cohort study explored the effect of adherence to follow-up colonoscopy after positive FOBT on risk of developing colon cancer ...
Researchers assessed whether using bispecific antibodies targeting CD20 and CD3 would reduce efficacy or increase toxicity in patients with relapsed or refractory non-Hodgkin B-cell lymphomas ...
Five-year overall and lung cancer-specific survival rates were similar for octogenarians and younger patients.
In this exploratory analysis from KEYNOTE-671, researchers examined event-free survival in NSCLC patients who received perioperative pembrolizumab but did not achieve a pCR.
Circulating tumor DNA can be detected in plasma samples sometimes several years prior to a clinical diagnosis of cancer, according to research published in Cancer. Cancer signal d ...
A presentation at the 2026 ONA Summit described the role of oncology nurses in managing the care of patients with NF-1 and PN undergoing treatment with MEK inhibitors.
Investigators analyzed the National Health Interview Survey 2019-2023 to determine adherence to influenza, pneumococcal, and shingles vaccines among adults with cancer aged 50 years or older.